Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0014
Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High Risk Localized Aggressive Histologies of Non-Hodgkin’s Lymphoma, Phase II
Research Committee(s)
Lymphoma
Activated
04-01-2000
Closed
01-15-2002
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9917
L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High Grade Prostatic Intraepithelial Neoplasia
Activated
02-01-2000
Closed
11-01-2006
Closed
Phase
Accrual
29%
SWOG Clinical Trial Number
S9918
A Phase II Study of Daunomycin and Ara-C Given by Continuous IV Infusion with PSC-833 for Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) in Patients of Age 56 or Older
Research Committee(s)
Leukemia
Activated
02-01-2000
Closed
03-15-2001
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S9909
Positron Emission Tomography (PET) Imaging of Lung Cancer Response to Therapy in Patients Registered to S9900
Research Committee(s)
Lung Cancer
Activated
12-15-1999
Closed
05-15-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9902
Evaluation of the Combination of Docetaxel (Taxotere®)/ Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN), Phase II
Research Committee(s)
Head and Neck Cancer
Activated
11-15-1999
Closed
01-01-2001
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9900
A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB(T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC).
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
07-15-2004
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S9914
Phase II Trial of Paclitaxel, Carboplatin and Topotecan with G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
06-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9916
Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-15-2003
Closed
Phase
Accrual
72%
SWOG Clinical Trial Number
S9921
Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-12-2007
Closed
Phase
Accrual
3%
SWOG Clinical Trial Number
S9903
A Phase II Pilot Study of Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
Research Committee(s)
Brain Cancer
Melanoma
Activated
07-15-1999
Closed
06-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9812
Pilot Study of l-Selenomethionine in Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy
Activated
06-15-1999
Closed
06-01-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S9804
Evaluation of Vinorelbine Tartrate (Navelbine®) in Patients with Disseminated Malignant Melanoma and at Least One Prior Systemic Therapy, Phase II.
Research Committee(s)
Melanoma
Activated
05-15-1999
Closed
08-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9911
A Phase II Pilot Trial of CHOP Followed By Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
05-15-1999
Closed
06-01-2000
Closed
Phase
Accrual
13%
Published
SWOG Clinical Trial Number
S9809
The Effect of Fluoroquinolones on the Disease-Free Interval in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
04-15-1999
Closed
07-01-2001
Closed
Phase
SWOG Clinical Trial Number
S9910
Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary
Research Committee(s)
Leukemia
Activated
04-15-1999
Closed
01-01-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9810
A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Research Committee(s)
Sarcoma
Activated
02-15-1999
Closed
08-15-2000
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
S9811
Phase II Study of Hydroxyurea for Unresectable Meningioma
Activated
11-15-1998
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9806
Randomized Phase II Trial of Carboplatin/Gemcitabine Followed by Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-01-1998
Closed
11-15-1999
Closed
Phase
Accrual
7%
SWOG Clinical Trial Number
S9716
A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)
Research Committee(s)
Melanoma
Activated
10-15-1998
Closed
08-15-2000
Closed
Phase
SWOG Clinical Trial Number
S9807
Repository for Paraffin Embedded Tissues from Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Research Committee(s)
Head and Neck Cancer
Activated
09-01-1998
Closed
02-15-2004